首页> 外文期刊>Allergy, Asthma & Immunology Research >A Case of Korean Ginseng-Induced Anaphylaxis Confirmed by Open Oral Challenge and Basophil Activation Test
【24h】

A Case of Korean Ginseng-Induced Anaphylaxis Confirmed by Open Oral Challenge and Basophil Activation Test

机译:口服挑战和嗜碱性粒细胞活化试验证实韩国人参致过敏反应一例

获取原文
           

摘要

Two case reports discussing Korean ginseng-induced allergic reactions have been published; both were inhalation-induced respiratory allergies in occupational settings. In this report we discuss the first case of anaphylaxis that developed after an oral intake of ginseng, confirmed by an open oral challenge, a skin prick test (SPT), and a basophil activation test (BAT). A 44-year-old man experienced rhinorrhea and nasal stiffness, followed by respiratory difficulty with wheeze and abdominal pain 10 minutes after oral intake of fresh ginseng. He had suffered from episodes of allergic rhinitis during the spring season for several years. Upon presentation, a physical examination, chest radiograph, and routine laboratory tests were unremarkable. Total serum IgE level was 41 IU/mL. The SPT results showed strong positive responses to alder, birch pollens, and ginseng extracts (1:500 w/v). The methacholine bronchial challenge test revealed a positive result at PC20 of 5.83 mg/mL. The open oral challenge was performed using 50 g of fresh ginseng and showed immediate onset of facial flushing, cough, respiratory difficulty with wheeze, and abdominal pain combined with a significant decrease in FEV1 levels (54% from the baseline). Serum-specific IgE and IgG4 antibodies were not detectable by enzyme-linked immunosorbent assay. BAT showed a remarkable increase in the expression of CD203c and CD63 with the addition of ginseng extract in a dose-dependent manner, while no changes were noted in the controls. In conclusion, oral intake of Korean ginseng could induce anaphylaxis, which is mediated by non-IgE-dependent direct activation of basophil/mast cells.
机译:已经发表了两个讨论韩国人参引起的过敏反应的病例报告;两者都是在职业环境中吸入引起的呼吸道过敏。在本报告中,我们讨论了口服摄入人参后出现的首例过敏反应,经开放式口服挑战,皮肤点刺试验(SPT)和嗜碱性粒细胞活化试验(BAT)证实。一名44岁的男子在口服新鲜人参10分钟后出现鼻漏和鼻腔僵硬,随后出现呼吸困难,喘息和腹痛。在春季,他患有过敏性鼻炎已有数年之久。出诊后,体检,胸部X光片检查和常规实验室检查均无异常。血清总IgE水平为41 IU / mL。 SPT结果显示出对al木,桦树花粉和人参提取物(1:500 w / v)的强烈阳性反应。乙酰甲胆碱支气管激发试验显示PC20为5.83 mg / mL时呈阳性结果。开放式口服挑战是使用50 g新鲜人参进行的,表现为立即出现面部潮红,咳嗽,喘息呼吸困难和腹痛,并伴有FEV1水平显着下降(较基线降低54%)。酶联免疫吸附法无法检测到血清特异性IgE和IgG4抗体。随着人参提取物剂量依赖性的增加,BAT表现出CD203c和CD63的表达显着增加,而对照中没有发现变化。总之,口服高丽参可引起过敏反应,这是由非IgE依赖的嗜碱性细胞/肥大细胞的直接激活介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号